Novel Squalestatins Produced by Biotransformation.

Robert F. Middleton, Graham Foster, Richard J. P. Cannell, Philip J. Sidebottom, NICHOLAS L. TAYLOR, David Noble, M.H. Todd, Michael J. Dawson, Gordon C. Lawrence

The Journal of Antibiotics · 1995 · 21 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

Microorganisms were screened for the ability to modify the squalene synthase inhibitor squalestatin 1. Biotransformation of 1 by two actinomycetes, S15106 and S15138, yielded three products hydroxylated on the 4,6-dimethyl-oct-2-enoyl side chain either at the 6 position (5) or 7 position (4 two diastereoisomers), and lacking the acetyl ester from the C-1 side chain. Many strains were found to hydrolyse the 4,6-dimethyl-oct-2-enoyl or acetyl esters to yield squalestatins 2 or 3. The 3-methyl ester (6) of 1 was obtained using Fusarium sp. F13945. This fungus also produced a farnesoic acid derivative, possibly in response to inhibition of its squalene synthase by 1. The biotransformation products of 1 all retained potent squalene synthase inhibitory activity.

References

8